A complete application in a minute
Tailored resume and cover letter, ready to send.
Syndax Pharmaceuticals seeks a Senior Medical Director, Clinical Development in New York to lead clinical development plans for a portfolio of oncology programs. You will drive study design, protocol development, and cross-functional collaboration with clinical operations, biometrics, and regulatory teams.
You will provide medical input for business development opportunities and help shape global regulatory strategy, ensuring rigorous safety monitoring and scientific integrity across projects.
Syndax Pharmaceuticals is looking for a Senior Medical Director, Clinical Development
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies.
The role will report to the Executive Medical Director in Clinical Development. The Senior Medical Director, Clinical Development is responsible for the creation and execution of clinical development plans within cross-functional project teams (clinical project managers, preclinical/clinical pharmacology, biometrics, regulatory, drug safety). The role will oversee several clinical stage assets and provide clinical input into business development opportunities as needed. They will work closely with key internal and external stakeholders, provide input into global regulatory strategy development and participate in the preparation of submission documents and responses to regulatory agency queries. They will be a strategic leader providing a strong, clear voice for the clinical program.
Syndax’s corporate office is in New York, NY.
Syndax offers a total compensation and rewards package that is among the most competitive in the industry. Base pay is just one element of our package and is determined within a range based on several factors including market data, experience, qualifications, demonstrated skills, relevant education or training, travel requirements and internal equity. Our overall package also includes an equity offering, annual target bonuses, and an outstanding benefits program. The anticipated annualized salary range for this role is $375,000 - $398,000.
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com/ or follow the Company on X and LinkedIn.
Syndax Pharmaceuticals is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
hematological malignancies hematology